nodes	percent_of_prediction	percent_of_DWPC	metapath
Mirtazapine—DRD4—Gilles de la Tourette syndrome	0.225	0.269	CbGaD
Mirtazapine—DRD3—Gilles de la Tourette syndrome	0.194	0.232	CbGaD
Mirtazapine—SLC6A3—Gilles de la Tourette syndrome	0.18	0.216	CbGaD
Mirtazapine—DRD2—Gilles de la Tourette syndrome	0.134	0.16	CbGaD
Mirtazapine—HTR2A—Gilles de la Tourette syndrome	0.104	0.124	CbGaD
Mirtazapine—SLC6A2—autonomic nervous system—Gilles de la Tourette syndrome	0.00406	0.0814	CbGeAlD
Mirtazapine—HTR7—autonomic nervous system—Gilles de la Tourette syndrome	0.00391	0.0785	CbGeAlD
Mirtazapine—HTR2A—autonomic nervous system—Gilles de la Tourette syndrome	0.00244	0.0489	CbGeAlD
Mirtazapine—HRH3—nervous system—Gilles de la Tourette syndrome	0.00159	0.032	CbGeAlD
Mirtazapine—HRH3—central nervous system—Gilles de la Tourette syndrome	0.00154	0.0308	CbGeAlD
Mirtazapine—HRH3—brain—Gilles de la Tourette syndrome	0.00122	0.0245	CbGeAlD
Mirtazapine—DRD4—brain—Gilles de la Tourette syndrome	0.0012	0.0241	CbGeAlD
Mirtazapine—DRD3—nervous system—Gilles de la Tourette syndrome	0.00111	0.0222	CbGeAlD
Mirtazapine—DRD3—central nervous system—Gilles de la Tourette syndrome	0.00106	0.0214	CbGeAlD
Mirtazapine—OPRK1—nervous system—Gilles de la Tourette syndrome	0.000985	0.0198	CbGeAlD
Mirtazapine—OPRK1—central nervous system—Gilles de la Tourette syndrome	0.000948	0.019	CbGeAlD
Mirtazapine—DRD3—brain—Gilles de la Tourette syndrome	0.000845	0.017	CbGeAlD
Mirtazapine—Mianserin—DRD3—Gilles de la Tourette syndrome	0.00079	0.245	CrCbGaD
Mirtazapine—SLC6A3—midbrain—Gilles de la Tourette syndrome	0.000774	0.0155	CbGeAlD
Mirtazapine—HTR3A—nervous system—Gilles de la Tourette syndrome	0.000764	0.0153	CbGeAlD
Mirtazapine—OPRK1—brain—Gilles de la Tourette syndrome	0.000753	0.0151	CbGeAlD
Mirtazapine—HTR2C—midbrain—Gilles de la Tourette syndrome	0.000748	0.015	CbGeAlD
Mirtazapine—HTR3A—central nervous system—Gilles de la Tourette syndrome	0.000736	0.0148	CbGeAlD
Mirtazapine—Mianserin—SLC6A3—Gilles de la Tourette syndrome	0.000735	0.228	CrCbGaD
Mirtazapine—Epinastine—HTR2A—Gilles de la Tourette syndrome	0.00073	0.226	CrCbGaD
Mirtazapine—SLC6A4—midbrain—Gilles de la Tourette syndrome	0.000709	0.0142	CbGeAlD
Mirtazapine—SLC6A3—nervous system—Gilles de la Tourette syndrome	0.000636	0.0128	CbGeAlD
Mirtazapine—HTR1A—midbrain—Gilles de la Tourette syndrome	0.000629	0.0126	CbGeAlD
Mirtazapine—HTR2C—nervous system—Gilles de la Tourette syndrome	0.000615	0.0123	CbGeAlD
Mirtazapine—SLC6A3—central nervous system—Gilles de la Tourette syndrome	0.000612	0.0123	CbGeAlD
Mirtazapine—ADRB1—nervous system—Gilles de la Tourette syndrome	0.000603	0.0121	CbGeAlD
Mirtazapine—HTR7—midbrain—Gilles de la Tourette syndrome	0.000602	0.0121	CbGeAlD
Mirtazapine—HTR2C—central nervous system—Gilles de la Tourette syndrome	0.000592	0.0119	CbGeAlD
Mirtazapine—HTR3A—brain—Gilles de la Tourette syndrome	0.000584	0.0117	CbGeAlD
Mirtazapine—SLC6A4—nervous system—Gilles de la Tourette syndrome	0.000583	0.0117	CbGeAlD
Mirtazapine—ADRB1—central nervous system—Gilles de la Tourette syndrome	0.000581	0.0117	CbGeAlD
Mirtazapine—HTR2B—nervous system—Gilles de la Tourette syndrome	0.000578	0.0116	CbGeAlD
Mirtazapine—DRD2—midbrain—Gilles de la Tourette syndrome	0.000569	0.0114	CbGeAlD
Mirtazapine—SLC6A4—central nervous system—Gilles de la Tourette syndrome	0.000561	0.0113	CbGeAlD
Mirtazapine—HTR2B—central nervous system—Gilles de la Tourette syndrome	0.000556	0.0112	CbGeAlD
Mirtazapine—ADRA2C—midbrain—Gilles de la Tourette syndrome	0.000553	0.0111	CbGeAlD
Mirtazapine—Mianserin—DRD2—Gilles de la Tourette syndrome	0.000547	0.17	CrCbGaD
Mirtazapine—HTR1A—nervous system—Gilles de la Tourette syndrome	0.000517	0.0104	CbGeAlD
Mirtazapine—SLC6A2—nervous system—Gilles de la Tourette syndrome	0.000513	0.0103	CbGeAlD
Mirtazapine—HTR1A—central nervous system—Gilles de la Tourette syndrome	0.000498	0.01	CbGeAlD
Mirtazapine—HTR7—nervous system—Gilles de la Tourette syndrome	0.000495	0.00993	CbGeAlD
Mirtazapine—SLC6A2—central nervous system—Gilles de la Tourette syndrome	0.000494	0.00992	CbGeAlD
Mirtazapine—SLC6A3—brain—Gilles de la Tourette syndrome	0.000486	0.00976	CbGeAlD
Mirtazapine—ADRA1A—nervous system—Gilles de la Tourette syndrome	0.000477	0.00957	CbGeAlD
Mirtazapine—HTR7—central nervous system—Gilles de la Tourette syndrome	0.000476	0.00956	CbGeAlD
Mirtazapine—HTR2C—brain—Gilles de la Tourette syndrome	0.00047	0.00943	CbGeAlD
Mirtazapine—DRD2—nervous system—Gilles de la Tourette syndrome	0.000468	0.00938	CbGeAlD
Mirtazapine—ADRB1—brain—Gilles de la Tourette syndrome	0.000461	0.00926	CbGeAlD
Mirtazapine—ADRA1A—central nervous system—Gilles de la Tourette syndrome	0.000459	0.00922	CbGeAlD
Mirtazapine—ADRA2C—nervous system—Gilles de la Tourette syndrome	0.000455	0.00912	CbGeAlD
Mirtazapine—DRD2—central nervous system—Gilles de la Tourette syndrome	0.00045	0.00904	CbGeAlD
Mirtazapine—SLC6A4—brain—Gilles de la Tourette syndrome	0.000445	0.00894	CbGeAlD
Mirtazapine—HTR2B—brain—Gilles de la Tourette syndrome	0.000441	0.00886	CbGeAlD
Mirtazapine—ADRA2A—midbrain—Gilles de la Tourette syndrome	0.000441	0.00886	CbGeAlD
Mirtazapine—ADRA2C—central nervous system—Gilles de la Tourette syndrome	0.000438	0.00878	CbGeAlD
Mirtazapine—Mianserin—HTR2A—Gilles de la Tourette syndrome	0.000422	0.131	CrCbGaD
Mirtazapine—HTR1A—brain—Gilles de la Tourette syndrome	0.000396	0.00794	CbGeAlD
Mirtazapine—SLC6A2—brain—Gilles de la Tourette syndrome	0.000392	0.00787	CbGeAlD
Mirtazapine—HTR7—brain—Gilles de la Tourette syndrome	0.000378	0.00759	CbGeAlD
Mirtazapine—HTR2A—midbrain—Gilles de la Tourette syndrome	0.000375	0.00753	CbGeAlD
Mirtazapine—HRH1—nervous system—Gilles de la Tourette syndrome	0.000369	0.00741	CbGeAlD
Mirtazapine—ADRA1A—brain—Gilles de la Tourette syndrome	0.000365	0.00732	CbGeAlD
Mirtazapine—ADRA2A—nervous system—Gilles de la Tourette syndrome	0.000363	0.00728	CbGeAlD
Mirtazapine—DRD2—brain—Gilles de la Tourette syndrome	0.000357	0.00717	CbGeAlD
Mirtazapine—HRH1—central nervous system—Gilles de la Tourette syndrome	0.000356	0.00714	CbGeAlD
Mirtazapine—ADRA2A—central nervous system—Gilles de la Tourette syndrome	0.000349	0.00701	CbGeAlD
Mirtazapine—ADRA2C—brain—Gilles de la Tourette syndrome	0.000347	0.00697	CbGeAlD
Mirtazapine—CYP2C8—brain—Gilles de la Tourette syndrome	0.000322	0.00647	CbGeAlD
Mirtazapine—HTR2A—nervous system—Gilles de la Tourette syndrome	0.000308	0.00619	CbGeAlD
Mirtazapine—HTR2A—central nervous system—Gilles de la Tourette syndrome	0.000297	0.00596	CbGeAlD
Mirtazapine—CYP3A4—nervous system—Gilles de la Tourette syndrome	0.000286	0.00573	CbGeAlD
Mirtazapine—HRH1—brain—Gilles de la Tourette syndrome	0.000282	0.00567	CbGeAlD
Mirtazapine—CYP2D6—nervous system—Gilles de la Tourette syndrome	0.000281	0.00564	CbGeAlD
Mirtazapine—ADRA2A—brain—Gilles de la Tourette syndrome	0.000277	0.00556	CbGeAlD
Mirtazapine—CYP3A4—central nervous system—Gilles de la Tourette syndrome	0.000275	0.00552	CbGeAlD
Mirtazapine—CYP2D6—central nervous system—Gilles de la Tourette syndrome	0.00027	0.00543	CbGeAlD
Mirtazapine—HTR2A—brain—Gilles de la Tourette syndrome	0.000236	0.00473	CbGeAlD
Mirtazapine—CYP2D6—brain—Gilles de la Tourette syndrome	0.000215	0.00431	CbGeAlD
Mirtazapine—HTR2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	6.24e-05	0.000563	CbGpPWpGaD
Mirtazapine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.23e-05	0.000562	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.22e-05	0.000561	CbGpPWpGaD
Mirtazapine—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.18e-05	0.000557	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.18e-05	0.000557	CbGpPWpGaD
Mirtazapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	6.11e-05	0.000551	CbGpPWpGaD
Mirtazapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD4—Gilles de la Tourette syndrome	6.1e-05	0.00055	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.08e-05	0.000549	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	6.05e-05	0.000546	CbGpPWpGaD
Mirtazapine—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	6.04e-05	0.000545	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	6.04e-05	0.000545	CbGpPWpGaD
Mirtazapine—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.91e-05	0.000533	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.91e-05	0.000532	CbGpPWpGaD
Mirtazapine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	5.89e-05	0.000531	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.89e-05	0.000531	CbGpPWpGaD
Mirtazapine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.88e-05	0.00053	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.88e-05	0.00053	CbGpPWpGaD
Mirtazapine—DRD3—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.81e-05	0.000523	CbGpPWpGaD
Mirtazapine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—Gilles de la Tourette syndrome	5.78e-05	0.000521	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.75e-05	0.000519	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.72e-05	0.000515	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.72e-05	0.000515	CbGpPWpGaD
Mirtazapine—HRH3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	5.68e-05	0.000512	CbGpPWpGaD
Mirtazapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD2—Gilles de la Tourette syndrome	5.68e-05	0.000512	CbGpPWpGaD
Mirtazapine—ADRA2C—Metabolism—HDC—Gilles de la Tourette syndrome	5.65e-05	0.000509	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.63e-05	0.000507	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.5e-05	0.000496	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.47e-05	0.000493	CbGpPWpGaD
Mirtazapine—SLC6A2—Transmembrane transport of small molecules—SLC6A3—Gilles de la Tourette syndrome	5.35e-05	0.000482	CbGpPWpGaD
Mirtazapine—DRD2—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.34e-05	0.000482	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	5.32e-05	0.00048	CbGpPWpGaD
Mirtazapine—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.29e-05	0.000477	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.28e-05	0.000476	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.26e-05	0.000474	CbGpPWpGaD
Mirtazapine—HRH1—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.25e-05	0.000473	CbGpPWpGaD
Mirtazapine—HTR7—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	5.2e-05	0.000469	CbGpPWpGaD
Mirtazapine—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.19e-05	0.000468	CbGpPWpGaD
Mirtazapine—DRD2—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.19e-05	0.000468	CbGpPWpGaD
Mirtazapine—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.18e-05	0.000467	CbGpPWpGaD
Mirtazapine—HRH3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	5.16e-05	0.000465	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	5.15e-05	0.000464	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.1e-05	0.00046	CbGpPWpGaD
Mirtazapine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5.09e-05	0.000459	CbGpPWpGaD
Mirtazapine—HRH1—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5.09e-05	0.000459	CbGpPWpGaD
Mirtazapine—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.06e-05	0.000456	CbGpPWpGaD
Mirtazapine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	5.04e-05	0.000454	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	5e-05	0.00045	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	5e-05	0.00045	CbGpPWpGaD
Mirtazapine—DRD4—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.98e-05	0.000449	CbGpPWpGaD
Mirtazapine—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.9e-05	0.000441	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	4.81e-05	0.000434	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR ligand binding—DRD3—Gilles de la Tourette syndrome	4.78e-05	0.000431	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.75e-05	0.000429	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.75e-05	0.000428	CbGpPWpGaD
Mirtazapine—HRH1—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.74e-05	0.000428	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.71e-05	0.000425	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	4.67e-05	0.000421	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.65e-05	0.00042	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—Gilles de la Tourette syndrome	4.64e-05	0.000419	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR ligand binding—DRD4—Gilles de la Tourette syndrome	4.64e-05	0.000419	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.64e-05	0.000418	CbGpPWpGaD
Mirtazapine—ADRA2A—Metabolism—HDC—Gilles de la Tourette syndrome	4.59e-05	0.000413	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.58e-05	0.000412	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.5e-05	0.000406	CbGpPWpGaD
Mirtazapine—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.44e-05	0.000401	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.44e-05	0.0004	CbGpPWpGaD
Mirtazapine—DRD3—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.42e-05	0.000399	CbGpPWpGaD
Mirtazapine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.36e-05	0.000393	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	4.35e-05	0.000392	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR ligand binding—DRD2—Gilles de la Tourette syndrome	4.33e-05	0.00039	CbGpPWpGaD
Mirtazapine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	4.28e-05	0.000386	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.28e-05	0.000386	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.26e-05	0.000384	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	4.24e-05	0.000382	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.21e-05	0.00038	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.2e-05	0.000378	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.16e-05	0.000375	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	4.12e-05	0.000371	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	4.09e-05	0.000369	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	4.03e-05	0.000364	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	4.03e-05	0.000363	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	4.02e-05	0.000362	CbGpPWpGaD
Mirtazapine—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—Gilles de la Tourette syndrome	3.98e-05	0.000359	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.94e-05	0.000355	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.87e-05	0.000349	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.85e-05	0.000347	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.85e-05	0.000347	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.83e-05	0.000346	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.83e-05	0.000346	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.83e-05	0.000345	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.81e-05	0.000344	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.74e-05	0.000337	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.73e-05	0.000336	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.65e-05	0.000329	CbGpPWpGaD
Mirtazapine—CYP2C8—Metabolism—HDC—Gilles de la Tourette syndrome	3.64e-05	0.000328	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.59e-05	0.000324	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.57e-05	0.000322	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.52e-05	0.000317	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.49e-05	0.000315	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.48e-05	0.000314	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.48e-05	0.000314	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.44e-05	0.00031	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.42e-05	0.000308	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.41e-05	0.000308	CbGpPWpGaD
Mirtazapine—DRD2—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.38e-05	0.000305	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.34e-05	0.000301	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.33e-05	0.0003	CbGpPWpGaD
Mirtazapine—HRH1—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.32e-05	0.000299	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.32e-05	0.000299	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.26e-05	0.000294	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.26e-05	0.000294	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.25e-05	0.000293	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	3.24e-05	0.000292	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	3.23e-05	0.000291	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.19e-05	0.000288	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.18e-05	0.000287	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.17e-05	0.000286	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.12e-05	0.000281	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.11e-05	0.00028	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.11e-05	0.00028	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.1e-05	0.000279	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.09e-05	0.000279	CbGpPWpGaD
Mirtazapine—HRH3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	3.05e-05	0.000275	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.03e-05	0.000273	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR ligand binding—HTR2A—Gilles de la Tourette syndrome	3.03e-05	0.000273	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	3.02e-05	0.000272	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	3.02e-05	0.000272	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	3.02e-05	0.000272	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	3.01e-05	0.000271	CbGpPWpGaD
Mirtazapine—CYP2D6—Metabolism—HDC—Gilles de la Tourette syndrome	2.99e-05	0.000269	CbGpPWpGaD
Mirtazapine—OPRK1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.99e-05	0.000269	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.97e-05	0.000268	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.96e-05	0.000267	CbGpPWpGaD
Mirtazapine—CYP2C9—Metabolism—HDC—Gilles de la Tourette syndrome	2.96e-05	0.000267	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.95e-05	0.000266	CbGpPWpGaD
Mirtazapine—HTR7—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.94e-05	0.000265	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.93e-05	0.000264	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.93e-05	0.000264	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.91e-05	0.000262	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.89e-05	0.00026	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.88e-05	0.00026	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.88e-05	0.000259	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.82e-05	0.000255	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.82e-05	0.000255	CbGpPWpGaD
Mirtazapine—DRD4—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.81e-05	0.000254	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.81e-05	0.000253	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.74e-05	0.000247	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.73e-05	0.000246	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.71e-05	0.000244	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—DRD3—Gilles de la Tourette syndrome	2.7e-05	0.000244	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.7e-05	0.000243	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.69e-05	0.000243	CbGpPWpGaD
Mirtazapine—HTR2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.69e-05	0.000242	CbGpPWpGaD
Mirtazapine—HTR2B—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.69e-05	0.000242	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.68e-05	0.000242	CbGpPWpGaD
Mirtazapine—HTR7—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.67e-05	0.000241	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.66e-05	0.00024	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.64e-05	0.000238	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.63e-05	0.000237	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—DRD4—Gilles de la Tourette syndrome	2.62e-05	0.000237	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.62e-05	0.000236	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.61e-05	0.000236	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.56e-05	0.000231	CbGpPWpGaD
Mirtazapine—DRD4—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.55e-05	0.00023	CbGpPWpGaD
Mirtazapine—CYP1A2—Metabolism—HDC—Gilles de la Tourette syndrome	2.53e-05	0.000228	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.53e-05	0.000228	CbGpPWpGaD
Mirtazapine—DRD3—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.5e-05	0.000225	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.49e-05	0.000224	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.45e-05	0.000221	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—DRD3—Gilles de la Tourette syndrome	2.45e-05	0.000221	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—DRD2—Gilles de la Tourette syndrome	2.44e-05	0.00022	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.44e-05	0.00022	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.44e-05	0.00022	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.43e-05	0.000219	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.42e-05	0.000218	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.39e-05	0.000215	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.38e-05	0.000215	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—DRD4—Gilles de la Tourette syndrome	2.38e-05	0.000215	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.29e-05	0.000206	CbGpPWpGaD
Mirtazapine—ADRB1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.28e-05	0.000205	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	2.27e-05	0.000205	CbGpPWpGaD
Mirtazapine—DRD3—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.27e-05	0.000205	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.25e-05	0.000203	CbGpPWpGaD
Mirtazapine—ADRB2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.23e-05	0.000201	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—DRD2—Gilles de la Tourette syndrome	2.22e-05	0.0002	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.21e-05	0.000199	CbGpPWpGaD
Mirtazapine—HTR1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.18e-05	0.000196	CbGpPWpGaD
Mirtazapine—HTR2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.17e-05	0.000195	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.15e-05	0.000194	CbGpPWpGaD
Mirtazapine—ADRA2C—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	2.11e-05	0.00019	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.07e-05	0.000186	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	2.06e-05	0.000185	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	2.05e-05	0.000185	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	2.02e-05	0.000182	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.98e-05	0.000178	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.97e-05	0.000177	CbGpPWpGaD
Mirtazapine—CYP3A4—Metabolism—HDC—Gilles de la Tourette syndrome	1.95e-05	0.000176	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.93e-05	0.000174	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.91e-05	0.000173	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.91e-05	0.000173	CbGpPWpGaD
Mirtazapine—DRD2—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.91e-05	0.000172	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.89e-05	0.00017	CbGpPWpGaD
Mirtazapine—HRH1—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.88e-05	0.000169	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.87e-05	0.000169	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.84e-05	0.000166	CbGpPWpGaD
Mirtazapine—ADRA1A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.84e-05	0.000166	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.84e-05	0.000165	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.83e-05	0.000165	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.79e-05	0.000161	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.78e-05	0.000161	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.78e-05	0.000161	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.74e-05	0.000157	CbGpPWpGaD
Mirtazapine—DRD2—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.74e-05	0.000157	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.73e-05	0.000156	CbGpPWpGaD
Mirtazapine—ADRA2A—GPCR downstream signaling—HTR2A—Gilles de la Tourette syndrome	1.71e-05	0.000154	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.71e-05	0.000154	CbGpPWpGaD
Mirtazapine—HRH1—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.71e-05	0.000154	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.67e-05	0.000151	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.67e-05	0.00015	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.66e-05	0.00015	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.62e-05	0.000146	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.61e-05	0.000146	CbGpPWpGaD
Mirtazapine—OPRK1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.6e-05	0.000144	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.59e-05	0.000144	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.59e-05	0.000143	CbGpPWpGaD
Mirtazapine—HTR7—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.58e-05	0.000142	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.57e-05	0.000142	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.56e-05	0.000141	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling by GPCR—HTR2A—Gilles de la Tourette syndrome	1.55e-05	0.00014	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.55e-05	0.000139	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.54e-05	0.000139	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.51e-05	0.000137	CbGpPWpGaD
Mirtazapine—DRD4—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.51e-05	0.000136	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD3—Gilles de la Tourette syndrome	1.45e-05	0.000131	CbGpPWpGaD
Mirtazapine—HTR2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.44e-05	0.00013	CbGpPWpGaD
Mirtazapine—HTR2B—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.44e-05	0.00013	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.44e-05	0.00013	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.41e-05	0.000127	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD4—Gilles de la Tourette syndrome	1.41e-05	0.000127	CbGpPWpGaD
Mirtazapine—DRD3—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.34e-05	0.000121	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—DRD2—Gilles de la Tourette syndrome	1.31e-05	0.000118	CbGpPWpGaD
Mirtazapine—ADRB1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.22e-05	0.00011	CbGpPWpGaD
Mirtazapine—ADRB2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.19e-05	0.000108	CbGpPWpGaD
Mirtazapine—HTR1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.17e-05	0.000105	CbGpPWpGaD
Mirtazapine—HTR2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.16e-05	0.000105	CbGpPWpGaD
Mirtazapine—ADRA2C—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.13e-05	0.000102	CbGpPWpGaD
Mirtazapine—DRD2—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.03e-05	9.25e-05	CbGpPWpGaD
Mirtazapine—HRH1—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	1.01e-05	9.08e-05	CbGpPWpGaD
Mirtazapine—ADRA1A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.88e-06	8.91e-05	CbGpPWpGaD
Mirtazapine—ADRA2A—Signaling Pathways—HTR2A—Gilles de la Tourette syndrome	9.18e-06	8.28e-05	CbGpPWpGaD
